Transplantation and cellular therapy

Long-Term Clinical Outcomes and B Cell Immune Reconstitution following Allo-HCT with Prophylactic, Post-Transplant Rituximab.

Transplantation and cellular therapy

Kennedy VE, Sahaf B, Wu F, Ehlinger ZJ, Arai S, Miklos DB

345 Prophylactic Tocilizumab Decreases Incidence of Acute Graft-Versus-Host Disease Following Alpha/Beta T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation in Children and Young Adults.

Transplantation and cellular therapy

Soohee Cho, Christopher C. Dvorak, Christine S. Higham, Gabriel Salinas Cisneros, Julia Chu, Alexis Melton, Lena E. Winestone, Kristin A. Shimano, Jasmeen Dara, Michelle Hermiston, James N. Huang, Janel Renee Long-Boyle, Sandhya Kharbanda

172 Diagnosing and Grading of SOS: Which Criteria Are Best?.

Transplantation and cellular therapy

Gabriel Salinas Cisneros, Christopher C. Dvorak, Sandhya Kharbanda, Kristin A. Shimano, Alexis Melton, Julia Chu, Lena E. Winestone, Jasmeen Dara, James N. Huang, Michelle Hermiston, Christine S. Higham

304 HLA-DPB1 Mismatch Permissiveness and Activating KIR Haplotypes Have Different Impact on Allogeneic Hematopoietic Cell Transplant Survival Outcomes in Acute Leukemias and Myelodysplastic Syndrome.

Transplantation and cellular therapy

Jerry Lee, Raja Rajalingam, Denice Kong, Weiyun Ai, Charalambos B. Andreadis, Lloyd E. Damon, Neil Dunavin, Karin M. Gaensler, Lawrence D. Kaplan, Thomas G. Martin, Rebecca L. Olin, Peter H. Sayre, Catherine C. Smith, Jeffrey L. Wolf, Aaron C. Logan

Patterns and predictors of functional decline after alloHCT in older adults.

Transplantation and cellular therapy

Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Huang CY, Olin RL

Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma.

Transplantation and cellular therapy

Banerjee R, Marsal J, Huang CY, Lo M, Kambhampati S, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N